SCHEMBL24046927

SCHEMBL24046927

C=CCOc1cnc(C=O)cc1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.49
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ ALDH1A1 P00352 7/20 0.42
▸ POLB P06746 2/20 0.42
▸ HPGD P15428 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ GAA P10253 3/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ FDPS P14324 1/20 0.41
▸ CYP2D6 P10635 1/20 0.40
▸ G6PD P11413 1/20 0.39
▸ PDE4B Q07343 2/20 0.37
▸ PDE4A P27815 1/20 0.37
▸ PDE4C Q08493 1/20 0.37
▸ PDE4D Q08499 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1223854 0.83 ALDH1A1 (0.47) KDM4EKMT2AMEN1ALDH1A1HPGD
SCHEMBL24046766 0.81 FDPS (0.42) KDM4EKMT2AMEN1ALDH1A1HPGD
SCHEMBL29652045 0.76 FDPS (0.71) KDM4EKMT2AMEN1ALDH1A1POLB
SCHEMBL1396839 0.76 FDPS (0.71) KDM4EKMT2AMEN1ALDH1A1POLB
SCHEMBL30389775 0.76 TRPC6 (0.44) FDPSPDE4BPDE4APDE4CPDE4D
SCHEMBL21750003 0.76 LMNA (0.45) KDM4EALDH1A1GAASMN1; SMN2MAPT
SCHEMBL29861038 0.76 LMNA (0.45) KDM4EALDH1A1GAASMN1; SMN2MAPT
SCHEMBL20529099 0.75 SMN1; SMN2 (0.51) KMT2AMEN1ALDH1A1HPGDSMN1; SMN2
SCHEMBL4144977 0.73 FDPS (0.41) KDM4EKMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL4152949 0.73 FDPS (0.40) KDM4EKMT2AMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021236578-A1 CHROMEN-4-ONE DERIVATIVES, SUCH AS E.G. FLAVONES, FOR USE AS CK2 INHIBITORS FOR THE TREATMENT OF NEUROINFLAMMATION SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2021-11-25 — — WO disclosed
Send feedback